{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:10:20Z","timestamp":1793243420963,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016105","name":"Quzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2022K63"],"award-info":[{"award-number":["2022K63"]}],"id":[{"id":"10.13039\/501100016105","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.tice.2025.103087","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T23:25:39Z","timestamp":1755127539000},"page":"103087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Dihydroartemisinin targets ANXA2 to suppress hepatocellular carcinoma angiogenesis through the PI3K\/AKT signaling pathway"],"prefix":"10.1016","volume":"97","author":[{"given":"Lulu","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4694-8753","authenticated-orcid":false,"given":"Junhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2025.103087_bib1","first-page":"93","article-title":"Protein expression profiles in a rat cirrhotic model induced by thioacetamide","volume":"12","author":"An","year":"2006","journal-title":"Korean J. Hepatol."},{"key":"10.1016\/j.tice.2025.103087_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.118991","article-title":"Plasma membrane wound repair is characterized by extensive membrane lipid and protein rearrangements in vascular endothelial cells","volume":"1868","author":"Ashraf","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Res"},{"key":"10.1016\/j.tice.2025.103087_bib3","doi-asserted-by":"crossref","first-page":"32946","DOI":"10.18632\/oncotarget.8783","article-title":"UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating annexin A2","volume":"7","author":"Bai","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2025.103087_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121772","article-title":"The ANXA2\/S100A10 complex-regulation of the oncogenic plasminogen receptor","volume":"11","author":"Bharadwaj","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.tice.2025.103087_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12029-017-9998-6","article-title":"Hepatocellular carcinoma with bone metastases: incidence, prognostic significance, and Management-Single-Center experience","volume":"48","author":"Bhatia","year":"2017","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.tice.2025.103087_bib6","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tice.2025.103087_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2025.103087_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16223764","article-title":"Annexin A2 in tumors of the gastrointestinal tract, liver, and pancreas","volume":"16","author":"Christofidis","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.tice.2025.103087_bib9","first-page":"199","article-title":"VEGF expression in pancreatic cancer and other malignancies: a review of the literature","volume":"53","author":"Costache","year":"2015","journal-title":"Rom. J. Intern Med."},{"key":"10.1016\/j.tice.2025.103087_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216596","article-title":"Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3\u03b2\/TCF7\/MMP9 pathway and synergies with capecitabine","volume":"582","author":"Dai","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2025.103087_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/ijbs.50364","article-title":"Dihydroartemisinin: a potential natural anticancer drug","volume":"17","author":"Dai","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tice.2025.103087_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13226828","article-title":"Dihydroartemisinin-Piperaquine combination in the treatment of uncomplicated plasmodium falciparum malaria: update on clinical failures in Africa and tools for surveillance","volume":"13","author":"Delandre","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tice.2025.103087_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.tice.2025.103087_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117221","article-title":"Dihydroartemisinin inhibits endothelial cell tube formation by suppression of the STAT3 signaling pathway","volume":"242","author":"Gao","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.tice.2025.103087_bib15","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1007\/s00210-024-03123-6","article-title":"Target prediction and potential application of dihydroartemisinin on hepatocarcinoma treatment","volume":"397","author":"Guo","year":"2024","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.tice.2025.103087_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.tice.2025.103087_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ijc.34048","article-title":"Annexin A2: the diversity of pathological effects in tumorigenesis and immune response","volume":"151","author":"Huang","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tice.2025.103087_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41420-025-02469-x","article-title":"ANXA2 in cancer: aberrant regulation of tumour cell apoptosis and its immune interactions","volume":"11","author":"Huang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.tice.2025.103087_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18335","article-title":"Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway","volume":"28","author":"Ji","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.tice.2025.103087_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112442","article-title":"Advances in anti hepatic fibrotic therapy with traditional Chinese Medicine herbal formula","volume":"251","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.tice.2025.103087_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112157","article-title":"Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer","volume":"133","author":"Li","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tice.2025.103087_bib22","article-title":"Dihydroartemisinin inhibits melanoma migration and metastasis by affecting angiogenesis","author":"Li","year":"2023","journal-title":"Phytother. Res"},{"key":"10.1016\/j.tice.2025.103087_bib23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1515\/hsz-2016-0166","article-title":"The annexin A2 system and angiogenesis","volume":"397","author":"Liu","year":"2016","journal-title":"Biol. Chem."},{"key":"10.1016\/j.tice.2025.103087_bib24","first-page":"199","article-title":"The role of annexin A2 in tumorigenesis and cancer progression","volume":"4","author":"Lokman","year":"2011","journal-title":"Cancer Micro"},{"key":"10.1016\/j.tice.2025.103087_bib25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/1389201021666200623132803","article-title":"Effects and mechanisms of anlotinib and dihydroartemisinin combination therapy in ameliorating malignant biological behavior of gastric cancer cells","volume":"22","author":"Luo","year":"2021","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.tice.2025.103087_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13046-018-0851-y","article-title":"ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis","volume":"37","author":"Ma","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tice.2025.103087_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-020-00916-7","article-title":"Annexin A2-STAT3-Oncostatin m receptor axis drives phenotypic and mesenchymal changes in glioblastoma","volume":"8","author":"Matsumoto","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tice.2025.103087_bib28","first-page":"1157","article-title":"Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma","volume":"33","author":"Mohammad","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tice.2025.103087_bib29","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3748\/wjg.v26.i18.2126","article-title":"Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment","volume":"26","author":"Qiu","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tice.2025.103087_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/carcin\/bgs372","article-title":"Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma","volume":"34","author":"Sun","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tice.2025.103087_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/308976","article-title":"Annexin A2: its molecular regulation and cellular expression in cancer development","volume":"2014","author":"Wang","year":"2014","journal-title":"Dis. Markers"},{"key":"10.1016\/j.tice.2025.103087_bib32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.20892\/j.issn.2095-3941.2019.0228","article-title":"Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism","volume":"16","author":"Wang","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.tice.2025.103087_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217846","article-title":"Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis","volume":"627","author":"Xiang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2025.103087_bib34","doi-asserted-by":"crossref","first-page":"802","DOI":"10.20892\/j.issn.2095-3941.2021.0661","article-title":"The advanced development of molecular targeted therapy for hepatocellular carcinoma","volume":"19","author":"Yan","year":"2022","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.tice.2025.103087_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","article-title":"Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies","volume":"20","author":"Yao","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.tice.2025.103087_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106393","article-title":"Correlating mechanical and gene expression data on the single cell level to investigate metastatic phenotypes","volume":"26","author":"Young","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.tice.2025.103087_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.722331","article-title":"Dihydroartemisinin: a potential drug for the treatment of malignancies and inflammatory diseases","volume":"11","author":"Yu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2025.103087_bib38","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1007\/s13277-015-3678-6","article-title":"Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.tice.2025.103087_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114228","article-title":"AGR2 facilitates teratoma progression by regulating glycolysis via the AnXA2\/EGFR axis","volume":"442","author":"Zhang","year":"2024","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tice.2025.103087_bib40","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.7150\/jca.92087","article-title":"Evodiamine inhibits colorectal cancer growth via RTKs mediated PI3K\/AKT\/p53 signaling pathway","volume":"15","author":"Zheng","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.tice.2025.103087_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119386","article-title":"Regulatory mechanisms of signaling pathways in liver cancer treatment with traditional Chinese Medicine","volume":"342","author":"Zheng","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.tice.2025.103087_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116730","article-title":"Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K\/AKT pathway and downregulating HIF-1\u03b1 expression","volume":"233","author":"Zhu","year":"2019","journal-title":"Life Sci."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625003696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625003696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:20:32Z","timestamp":1779891632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816625003696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":42,"alternative-id":["S0040816625003696"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2025.103087","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydroartemisinin targets ANXA2 to suppress hepatocellular carcinoma angiogenesis through the PI3K\/AKT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2025.103087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103087"}}